doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
Store reconstituted material refrigerated (28C) and use within ~4 weeks
Supports Cellular and Tissue Health: L-carnosine might support skin, muscle, and organ health, contributing to overall development in growing children by promoting healthy cell function and tissue maintenance
GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response
The components necessary to make authentic vegan collagen are inexpensive and easily obtained
Studies in BBS knockout mice, such as those lacking Bbs2 , Bbs4 , or Bbs6 , show increased obesity due to both increased food intake and reduced energy expenditure